The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems

Area of Science:

• Hematology
• Immunology
• Oncology

Background:

• Immunomagnetic separation using anti-CD34 antibodies enriches hematopoietic stem cells (HSCs).
• This technique offers a novel approach for purging tumor cells from HSC collections.

Purpose of the Study:

• To evaluate the efficiency of immunomagnetic separation in purging CD34-negative tumor cells from mobilized peripheral blood mononuclear cells (PBMNCs).
• To assess the purity and yield of CD34+ HSCs obtained using the Isolex 50 magnetic separator.

Main Methods:

• Mobilized PBMNCs from patients with solid tumors or multiple myeloma were intentionally contaminated with tumor cells.
• Cells were processed using anti-CD34 antibodies and paramagnetic microbeads with the Isolex 50 system.
• Purification was analyzed by flow cytometry, and tumor cell depletion was assessed using human tumor cloning assays (HTCA).

Main Results:

• Median purity of CD34+ cells was 85.9% (range 69.8-92.9%), with a median yield of 48.1% (range 21.0-85.2%).
• Median tumor cell depletion was 2.75 log (range 1.55-3.69 log), with a yield-corrected median depletion of 2.38 log (range 1.48-3.15 log).
• Significant variations in depletion efficacy were observed, suggesting dependence on tumor cell surface characteristics and potential influence of plasma factors.

Conclusions:

• The Isolex 50 system effectively achieves high purity of CD34+ cells and efficient tumor cell depletion.
• Calculated and experimentally determined tumor cell purging efficiencies may not always align.
• Further investigation into factors influencing depletion efficacy is warranted.